tiprankstipranks
Trending News
More News >
Universe Pharmaceuticals (UPC)
NASDAQ:UPC
US Market

Universe Pharmaceuticals (UPC) Financial Statements

Compare
212 Followers

Universe Pharmaceuticals Financial Overview

Universe Pharmaceuticals's market cap is currently $2.48M. The company's EPS TTM is $; its P/E ratio is -0.45; Universe Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 17.86M$ 23.02M$ 32.31M$ 40.14M$ 47.98M
Gross Profit$ 6.30M$ 6.07M$ 10.32M$ 21.89M$ 25.33M
Operating Income$ -2.92M$ -8.02M$ -3.53M$ -7.02M$ 13.59M
EBITDA$ -2.92M$ -7.36M$ -3.18M$ -6.40M$ 14.20M
Net Income$ -3.67M$ -8.73M$ -6.16M$ -8.74M$ 11.32M
Balance Sheet
Cash & Short-Term Investments$ 33.59M$ 29.50M$ 18.50M$ 18.86M$ 21.80M
Total Assets$ 69.30M$ 67.95M$ 53.29M$ 59.54M$ 70.14M
Total Debt$ 9.26M$ 7.99M$ 5.48M$ 3.94M$ 4.33M
Net Debt$ -24.34M$ -21.50M$ 197.21K$ -1.78M$ -3.74M
Total Liabilities$ 13.17M$ 22.45M$ 13.75M$ 13.10M$ 11.21M
Stockholders' Equity$ 56.13M$ 45.50M$ 39.53M$ 46.44M$ 58.93M
Cash Flow
Free Cash Flow$ -5.40M$ -9.87M$ 1.08M$ -1.41M$ -15.59M
Operating Cash Flow$ -5.05M$ -9.51M$ 1.12M$ -1.31M$ -2.06M
Investing Cash Flow$ -341.81K$ -361.29K$ -44.17K$ -3.91M$ -27.06M
Financing Cash Flow$ 9.73M$ 33.95M$ -1.39M$ 3.32M$ 26.58M
Currency in USD

Universe Pharmaceuticals Earnings and Revenue History

Universe Pharmaceuticals Debt to Assets

Universe Pharmaceuticals Cash Flow

Universe Pharmaceuticals Forecast EPS vs Actual EPS